Natco Pharma Ltd (NATP.NS) announced it has received tentative approval from the USFDA for Erdafitinib tablets. The approval marks a significant milestone in oncology therapeutics, strengthening Natco’s global portfolio and reinforcing its presence in the high-value cancer treatment segment.
Show moreStay Ahead – Explore Now! Kpi Green Energy Commences Power Supply From 240 Mw Solar Project
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
